Transcriptional regulation of cuproptosis resistance in cancer therapy
- PMID: 40571556
- PMCID: PMC12350063
- DOI: 10.1016/j.trecan.2025.06.006
Transcriptional regulation of cuproptosis resistance in cancer therapy
Abstract
Cuproptosis is a newly identified form of copper-dependent cell death. Recent studies show that solid tumors evade this process through transcriptional reprogramming, including hypoxia inducible factor 1 subunit alpha (HIF1A) and NFE2 like BZIP transcription factor 2 (NFE2L2) activation and BTB domain and CNC homolog 1 (BACH1) suppression. Targeting these pathways may restore cuproptosis sensitivity, offering a promising strategy to overcome therapy resistance in cancer.
Keywords: copper metabolism; cuproptosis; therapy resistance; transcription factor; tumor metabolism.
Copyright © 2025 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Similar articles
-
Hypoxia-induced upregulation of HIF1A-AS3 promotes MSC transition to cancer-associated fibroblasts and confers drug resistance in gastric cancer.Drug Resist Updat. 2025 Sep;82:101275. doi: 10.1016/j.drup.2025.101275. Epub 2025 Jul 14. Drug Resist Updat. 2025. PMID: 40706422
-
LncRNA PVT1 promotes cuproptosis through transcriptional activation of FDX1 in colorectal cancer.Redox Biol. 2025 Sep;85:103722. doi: 10.1016/j.redox.2025.103722. Epub 2025 Jun 7. Redox Biol. 2025. PMID: 40505346 Free PMC article.
-
Hypoxia, cuproptosis, and osteoarthritis: Unraveling the molecular crosstalk.Redox Biol. 2025 Sep;85:103757. doi: 10.1016/j.redox.2025.103757. Epub 2025 Jul 8. Redox Biol. 2025. PMID: 40669206 Free PMC article.
-
Cuproptosis: a novel therapeutic mechanism in lung cancer.Cancer Cell Int. 2025 Jun 24;25(1):231. doi: 10.1186/s12935-025-03864-1. Cancer Cell Int. 2025. PMID: 40555995 Free PMC article. Review.
-
Cuproptosis: Current insights into its multifaceted role in disease, cancer, and translational/therapeutic opportunities.Biomed Pharmacother. 2025 Sep;190:118422. doi: 10.1016/j.biopha.2025.118422. Epub 2025 Aug 6. Biomed Pharmacother. 2025. PMID: 40774019 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous